Biotech Values

[DewDiligence]

MRX is trying hard to establish Dysport in the US market but,
so far, it’s not working too well. In this promotion, MRX gives
users $75 off their next treatment even if they switch to Botox.

http://finance.yahoo.com/news/Medicis-Extends-the-Popular-pz-3379048195.html?x=0&.v=1

›Medicis Extends the Popular DYSPORT™ Challenge by One Month

April 27, 2010, 4:16 pm EDT

SCOTTSDALE, Ariz., April 27, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE: MRX ) today announced it has extended the "Dysport Challenge: Love It or Leave It" for Dysport (abobotulinumtoxinA) 300 Units for Injection through May 31, 2010, due to its popularity. Approved by the U.S. Food and Drug Administration (FDA) in April 2009, Dysport is a prescription injection used to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age.

"We are so pleased with the overwhelming response in just two months from patients who have registered for the Dysport Challenge that we are extending the program through May 31," said Jonah Shacknai, Chairman and Chief Executive Officer of Medicis. "We were so confident patients would love Dysport that we introduced the Dysport Challenge on March 1, allowing patients to try Dysport and save $75. We went a step further to offer those patients who chose 'Love It' another $75 off their next Dysport treatment for a total savings of $150.

Patients who do not love their Dysport treatment can have their frown lines treated with another botulinum toxin type A product [LOL—Botox is the only other option in the US] as prescribed by their physician and receive a $75 rebate. To date, tens of thousands of patients have registered for the Dysport Challenge."

The Dysport Challenge was launched on March 1 and now runs through May 31, 2010. Offer terms and conditions apply. For complete offer details, please see below, visit www.DysportUSA.com or talk to your licensed healthcare professional. Ask your healthcare professional if Dysport is right for you.‹